Literature DB >> 23397514

Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis.

Morven Caroline Brown1, Kate Elizabeth Best, Mark Stephen Pearce, Jason Waugh, Stephen Courtenay Robson, Ruth Bell.   

Abstract

There is increasing evidence that pre-eclampsia, a principal cause of maternal morbidity, may also be a risk factor for future cardiovascular and cerebrovascular events. This review aimed to assess the current evidence and quantify the risks of cardiovascular disease (CVD), cerebrovascular events and hypertension associated with prior diagnosis of pre-eclampsia. Medline and Embase were searched with no language restrictions, as were core journals and reference lists from reviews up until January 2012. Case-control and cohort studies which reported cardiovascular and cerebrovascular diseases or hypertension diagnosed more than 6 weeks postpartum, in women who had a history of pre-eclampsia relative to women who had unaffected pregnancies, were included. Fifty articles were included in the systematic review and 43 in the meta-analysis. Women with a history of pre-eclampsia or eclampsia were at significantly increased odds of fatal or diagnosed CVD [odds ratio (OR) = 2.28, 95% confidence interval (CI): 1.87, 2.78], cerebrovascular disease (OR = 1.76, 95% CI 1.43, 2.21) and hypertension [relative risk (RR) = 3.13, 95% CI 2.51, 3.89]. Among pre-eclamptic women, pre-term delivery was not associated with an increased risk of a future cardiovascular event (RR = 1.32, 95% CI 0.79, 2.22). Women diagnosed with pre-eclampsia are at increased risk of future cardiovascular or cerebrovascular events, with an estimated doubling of odds compared to unaffected women. This has implications for the follow-up of all women who experience pre-eclampsia, not just those who deliver pre-term. This association may reflect shared common risk factors for both pre-eclampsia and cardiovascular and cerebrovascular disease.

Entities:  

Mesh:

Year:  2013        PMID: 23397514     DOI: 10.1007/s10654-013-9762-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  86 in total

1.  Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study.

Authors:  P Croft; P C Hannaford
Journal:  BMJ       Date:  1989-01-21

2.  Long-term prognosis of hypertension in pregnancy.

Authors:  R Marín; M Gorostidi; C G Portal; M Sánchez; E Sánchez; J Alvarez
Journal:  Hypertens Pregnancy       Date:  2000       Impact factor: 2.108

3.  What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia.

Authors:  R A North; D Simmons; D Barnfather; M Upjohn
Journal:  Aust N Z J Obstet Gynaecol       Date:  1996-08       Impact factor: 2.100

4.  Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort.

Authors:  G Libby; D J Murphy; N F McEwan; S A Greene; J S Forsyth; P W Chien; A D Morris
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

5.  Decreased arterial elasticity in formerly early-onset preeclamptic women.

Authors:  Esteban T D Souwer; Judith Blaauw; Sophie M Coffeng; Andries J Smit; Jasper J Van Doormaal; Marijke M Faas; Maria G Van Pampus
Journal:  Acta Obstet Gynecol Scand       Date:  2011-05-20       Impact factor: 3.636

6.  Dyslipoproteinaemia in postmenopausal women with a history of eclampsia.

Authors:  C A Hubel; S Snaedal; R B Ness; L A Weissfeld; R T Geirsson; J M Roberts; R Arngrímsson
Journal:  BJOG       Date:  2000-06       Impact factor: 6.531

7.  Preeclampsia is associated with persistent postpartum cardiovascular impairment.

Authors:  Karen Melchiorre; George Ross Sutherland; Marco Liberati; Basky Thilaganathan
Journal:  Hypertension       Date:  2011-08-15       Impact factor: 10.190

8.  Long-term mortality after preeclampsia.

Authors:  Edmund F Funai; Yechiel Friedlander; Ora Paltiel; Efrat Tiram; Xiaonan Xue; Lisa Deutsch; Susan Harlap
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

9.  Remote prognosis of preeclampsia in women 25 years old and younger.

Authors:  H Carleton; A Forsythe; R Flores
Journal:  Am J Obstet Gynecol       Date:  1988-07       Impact factor: 8.661

10.  Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors.

Authors:  Elisabeth B Magnussen; Lars J Vatten; George Davey Smith; Pål R Romundstad
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

View more
  183 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.

Authors:  Rebeccah A McKibben; Mahmoud Al Rifai; Lena M Mathews; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-12-29

3.  Liver: Links between hepatobiliary diseases in and beyond pregnancy.

Authors:  Lucy C Chappell; Catherine Williamson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-28       Impact factor: 46.802

4.  The Relationship of Restless Legs Syndrome to History of Pregnancy-Induced Hypertension.

Authors:  Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe
Journal:  J Womens Health (Larchmt)       Date:  2016-02-25       Impact factor: 2.681

Review 5.  The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.

Authors:  Anandita Agarwala; Erin D Michos; Zainab Samad; Christie M Ballantyne; Salim S Virani
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

6.  New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.

Authors:  N Kweider; C J Wruck; W Rath
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

7.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.

Authors:  Mark W Cunningham; Javier Castillo; Tarek Ibrahim; Denise C Cornelius; Nathan Campbell; Lorena Amaral; Venkata Ramana Vaka; Nathan Usry; Jan M Williams; Babbette LaMarca
Journal:  Hypertension       Date:  2018-03-19       Impact factor: 10.190

Review 8.  Current Updates on Pre-eclampsia: Maternal and Foetal Cardiovascular Diseases Predilection, Science or Myth? : Future cardiovascular disease risks in mother and child following pre-eclampsia.

Authors:  Samson A Odukoya; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-03-10       Impact factor: 5.369

9.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

10.  The Broken Thread of Health Promotion and Disease Prevention for Women During the Postpartum Period.

Authors:  Lorraine O Walker; Christina L Murphey; Francine Nichols
Journal:  J Perinat Educ       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.